Insulet Corporation

This study tested the safety and effectiveness of the Omnipod 5 SmartAdjust 2.0 system, an automated insulin pump, in 48 people aged 2 to 70 with type 1 or type 2 diabetes. The system uses a continuous glucose monitor to automatically adjust insulin delivery. The main goals were …

This study tested whether the Omnipod 5 insulin pump, which automatically adjusts insulin, works better than multiple daily injections for managing type 1 diabetes. 189 children and adults used either the pump or injections, along with a continuous glucose monitor. The main goal …

This study tested different starting doses of insulin using an automated delivery system (Omnipod M) in 56 adults with type 2 diabetes. The goal was to see if a simplified onboarding process is safe and helps control blood sugar levels. Participants used the system for up to 12 w…

This study tested the Omnipod M System, a wearable insulin pump, in 40 adults aged 18-75 with type 2 diabetes. The goal was to see if the system helps keep blood sugar levels in a safe range and reduces dangerous highs and lows. Participants used the system for 6 weeks while rese…

This study tested the Omnipod 5, a wearable automated insulin delivery system, in 343 adults with type 2 diabetes who need insulin. The goal was to see if the system safely improves blood sugar control. Participants used the device for 13 weeks, and researchers measured changes i…

This study tested whether the Omnipod 5 system, which automatically adjusts insulin, works better than standard insulin pumps for adults with type 1 diabetes. 196 people took part, first using their usual therapy for 14 days, then either switching to Omnipod 5 or staying on their…

This study tested a new version of the Omnipod insulin pump (SmartAdjust 2.0) against the current Omnipod 5 system in 132 people with type 1 or type 2 diabetes, ages 2 to 70. Participants used each system for about 4 weeks to compare how well they kept blood sugar in a healthy ra…